Furthermore, FXR signaling did not appear to be significantly altered in patients with active CDI disease since no differences were evident in downstream serum FGF-19 levels when compared with age-matched hospitalized controls without diarrhea (S6 Fig). The gene discussed is FGF19; the disease is clostridium difficile infection.